Intrinsic Value
Celyad Oncology SA (CYAD)
$0.47
-0.07 (-12.96%)
Enterprise Value | -7.62 |
---|---|
Net Debt | -12.19 |
Equity Value | 4.57 |
Shares Outstanding | 22.59 |
Equity Value Per Share | 0.20 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt